Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells

Microvascular Research

Volumn 75, Issue 3, 2008, Pages 351-357

  Robillard, Kevin R ^a   Bone, Derek B J ^a   Hammond, James R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cell culture isolation; Endothelial function; Ischemia reperfusion; Membrane transport; Microcirculation

Indexed keywords

EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; HYPOXANTHINE; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; BLOOD VESSEL; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MEMBRANE TRANSPORT; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN TRANSPORT; RAT; SKELETAL MUSCLE; THIN LAYER CHROMATOGRAPHY;

ALLOPURINOL; ANIMALS; ANTIMETABOLITES; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHROMATOGRAPHY, THIN LAYER; DEOXYGLUCOSE; ENDOTHELIUM, VASCULAR; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; HYPOXANTHINE; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; RATS; RATS, WISTAR; ROTENONE; TRITIUM; UNCOUPLING AGENTS;

RATTUS;

EID: 41949087546     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2007.10.002     Document Type: Article

References (40)

1. Abd-Elfattah A.S., and Wechsler A.S. Separation between ischemic and reperfusion injury by site specific entrapment of endogenous adenosine and inosine using NBMPR and EHNA. J. Card. Surg. 9 (1994) 387-396
2. Abd-Elfattah A.S., Jessen M.E., Lekven J., Doherty III N.E., Brunsting L.A., and Wechsler A.S. Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury. Circulation 78 (1988) III224-III235
3. Arch J.R.S., and Newsholme E.A. The control of the metabolism and the hormonal role of adenosine. Essays Biochem. 14 (1978) 82-123
4. Archer R.G., Pitelka V., and Hammond J.R. Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells. Br. J. Pharmacol. 143 (2004) 202-214
5. Ashraf M. Myocardial ischemia-reperfusion injury: free radicals. In: Thomas C., and Kalyanaraman B. (Eds). Oxygen Radicals and Disease Process (1997), Rjordon and Breach Publishing Group 175-218
6. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E., and Young J.D. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447 (2004) 735-743
7. Beetsch J.W., Park T.S., Dugan L.L., Shah A.R., and Gidday J.M. Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells. Brain Res. 786 (1998) 89-95
8. Berry C.E., and Hare J.M. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555 (2004) 589-606
9. 1 receptors. J. Physiol. (Lond) 514 Pt 1 (1999) 151-162
10. Buolamwini J.K. Nucleoside transport inhibitors: structure-activity relationships and potential therapeutic applications. Curr. Med. Chem. 4 (1997) 35-66
11. Bzowska A., Kulikowska E., and Shugar D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol. Ther. 88 (2000) 349-425
12. Crawford C.R., Patel D.H., Naeve C., and Belt J.A. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. 273 (1998) 5288-5293
13. Deussen A., Bading B., Kelm M., and Schrader J. Formation and salvage of adenosine by macrovascular endothelial cells. Am. J. Physiol. 264 (1993) H692-H700
14. Deussen A., Stappert M., Schafer S., and Kelm M. Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient. Circulation 99 (1999) 2041-2047
15. Gamboa A., Ertl A.C., Costa F., Farley G., Manier M.L., Hachey D.L., Diedrich A., and Biaggioni I. Blockade of nucleoside transport is required for delivery of intraarterial adenosine into the interstitium. Relevance to therapeutic preconditioning in humans. Circulation 108 (2003) 2631-2635
16. Glantzounis G.K., Tsimoyiannis E.C., Kappas A.M., and Galaris D.A. Uric acid and oxidative stress. Curr. Pharm. Des. 11 (2005) 4145-4151
17. Hammond J.R. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity. Naunyn Schmiedebergs Arch. Pharmacol. 361 (2000) 373-382
18. Hewett P.W., and Murray J.C. Human microvessel endothelial cells: isolation, culture and characterization. In Vitro Cell Dev. Biol. Anim. 29A (1993) 823-830
19. Hewett P.W., and Murray J.C. Immunomagnetic purification of human microvessel endothelial cells using Dynabeads coated with monoclonal antibodies to PECAM-1. Eur. J. Cell Biol. 62 (1993) 451-454
20. Houston M., Estevez A., Chumley P., Aslan M., Marklund S., Parks D.A., and Freeman B.A. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J. Biol. Chem. 274 (1999) 4985-4994
21. Hyde R.J., Cass C.E., Young J.D., and Baldwin S.A. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol. Membr. Biol. 18 (2001) 53-63
22. Jacobson K.A., and Gao Z.G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5 (2006) 247-264
23. Jaffe E.A. Cell biology of endothelial cells. Hum. Pathol. 18 (1987) 234-239
24. Kinugasa Y., Ogino K., Furuse Y., Shiomi T., Tsutsui H., Yamamoto T., Igawa O., Hisatome I., and Shigemasa C. Allopurinol improves cardiac dysfunction after ischemia reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ. J. 67 (2003) 781-787
25. Kline P.C., and Schramm V.L. Purine nucleoside phosphorylase. Inosine hydrolysis, tight binding of the hypoxanthine intermediate, and third-the-sites reactivity. Biochemistry 31 (1992) 5964-5973
26. Kochan Z., Smolenski R.T., Yacoub M.H., and Seymour A.L. Nucleotide and adenosine metabolism in different cell types of human and rat heart. J. Mol. Cell Cardiol. 26 (1994) 1497-1503
27. Kraupp M., Marz R., Prager G., Kommer W., Razavi M., Baghestanian M., and Chiba P. Adenine and hypoxanthine transport in human erythrocytes: distinct substrate effects on carrier mobility. Biochim. Biophys. Acta 1070 (1991) 157-162
28. Loffler M., Morote-Garcia J.C., Eltzschig S.A., Coe I.R., and Eltzschig H.K. Physiological roles of vascular nucleoside transporters. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1004-1013
29. Marshall J.M. Adenosine and muscle vasodilatation in acute systemic hypoxia. Acta Physiol. Scand. 168 (2000) 561-573
30. Metz S., Holland S., Johnson L., Espling E., Rabaglia M., Segu V., Brockenbrough J.S., and Tran P.O. Inosine-5′-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells. Endocrinology 142 (2001) 193-204
31. Nagai K., Nagasawa K., Matsunaga R., Yamaji M., and Fujimoto S. Novel Na(+)-independent and adenine-specific transport system for adenine in primary cultured rat cortical neurons. Neurosci. Lett. 407 (2006) 244-248
32. Noji T., Karasawa A., and Kusaka H. Adenosine uptake inhibitors. Eur. J. Pharmacol. 495 (2004) 1-16
33. Norman B., Sollevi A., Kaijser L., and Jansson E. ATP breakdown products in human skeletal muscle during prolonged exercise to exhaustion. Clin. Physiol. 7 (1987) 503-510
34. Rouquette M., Page S., Bryant R., Benboubetra M., Stevens C.R., Blake D.R., Whish W.D., Harrison R., and Tosh D. Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture. FEBS Lett. 426 (1998) 397-401
35. Shimizu H., Daly J.W., and Creveling C.R. A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J. Neurochem. 16 (1969) 1609-1619
36. Shryock J.C., and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. 79 (1997) 2-10
37. Sommerschild H.T., and Kirkeboen K.A. Adenosine and cardioprotection during ischaemia and reperfusion-an overview. Acta Anaesthesiol. Scand. 44 (2000) 1038-1055
38. Ward J.L., Sherali A., Mo Z.P., and Tse C.M. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J. Biol. Chem. 275 (2000) 8375-8381
39. Weigel G., Griesmacher A., and Müller M.M. Endothelial purine metabolism and reperfusion injury. Adv. Exp. Med. Biol. 431 (1998) 359-364
40. Wilson J.X., Dixon S.J., Yu J., Nees S., and Tyml K. Ascorbate uptake by microvascular endothelial cells of rat skeletal muscle. Microcirculation 3 (1996) 211-221